Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

STRATA Skin Sciences (SSKN) Income from Continuing Operations (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Income from Continuing Operations for 14 consecutive years, with 70000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 101.48% to 70000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6249000.0 through Dec 2025, up 43.8% year-over-year, with the annual reading at 6261000.0 for FY2025, 38.19% up from the prior year.
  • Income from Continuing Operations hit 70000.0 in Q4 2025 for STRATA Skin Sciences, up from 1622000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1082000.0 in Q2 2021 to a low of 4725000.0 in Q4 2024.
  • Historically, Income from Continuing Operations has averaged 1779850.0 across 5 years, with a median of 1983000.0 in 2022.
  • Biggest five-year swings in Income from Continuing Operations: surged 164.4% in 2021 and later crashed 3138.33% in 2023.
  • Year by year, Income from Continuing Operations stood at 849000.0 in 2021, then soared by 85.87% to 120000.0 in 2022, then plummeted by 3138.33% to 3886000.0 in 2023, then fell by 21.59% to 4725000.0 in 2024, then surged by 101.48% to 70000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for SSKN at 70000.0 in Q4 2025, 1622000.0 in Q3 2025, and 2575000.0 in Q2 2025.